How biopharma can apply AI and machine learning to enhance business development activities

11:05 AM - 11:50 AM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

Reliable and in-depth business development intelligence is critical to sustaining biopharma innovation engines. Too often, companies large and small set strategies and pursue deals based on spotty, siloed analytics and suffer disappointing ROI as a result.

Is there a role for AI and machine learning to play in enhancing this vital corporate function in the life sciences? Could AI act as a force multiplier for human intelligence in performing due diligence and identifying whitespace opportunities?

In this panel discussion, Clarivate’s Mike Ward, a veteran life science journalist, will talk to biopharma industry leaders and venture capitalists about: 

• The business development challenges that could be informed by the use of AI and machine learning tools;
• What sorts of cultural, organizational and technological shifts would be needed within biopharmas to enable an AI-enhanced approach to business development;
• How companies and investors are beginning to use these technologies to understand risks and opportunities and inform business strategy.

Sponsored By